Skip to main content
OpenTrials

Clinical trial condition

Lupus Erythematosus, Systemic

Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.

840 public trials 218 recruiting studies
Refine in advanced search Browse all conditions

Lupus Erythematosus, Systemic trial results

Completed

A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus

NCT06013995

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +6 more
Locations
  • Local Institution - 0048 San Diego, California, United States
  • Local Institution - 0055 Clearwater, Florida, United States
  • Local Institution - 0029 Tampa, Florida, United States
  • Skin Sciences Louisville, Kentucky, United States
View all 20 locations
View Trial Details
Completed

RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome

NCT03684564

Conditions
Antiphospholipid Syndrome, Autoimmune Diseases, Brain Diseases, +13 more
Locations
  • Epsom and St Helier University Hospitals NHS Trust Epsom, United Kingdom
  • Barts and the London Hospitals, Barts Health NHS Trust London, United Kingdom
  • Hammersmith Hospital, Imperial College Healthcare NHS Trust London, United Kingdom
  • Kings College Hospital NHS Foundation Trust London, United Kingdom
View Trial Details
Completed

Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy.

NCT01687192

Conditions
Autoimmune Diseases, Blood-Borne Infections, Communicable Diseases, +19 more
Locations
  • CHU de Bordeaux, Hôpital Pellegrin-Enfants Bordeaux, France
  • HCLyon, Hôpital Femme-mère-enfant Bron, France
  • CHU de Lille, Hôpital Jeanne de Flandres Lille, France
  • CHU de Montpellier, Hôpital Arnaud de Villeneuve Montpellier, France
View Trial Details
Completed

Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients

NCT03656562

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Novartis Investigative Site Caba, Argentina
  • Novartis Investigative Site Clayton, Victoria, Australia
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Nanjing, Jiangsu, China
View all 31 locations
View Trial Details
Completed

A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus

NCT05856448

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • University of Arizona College of Medicine - Tucson Tucson, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • Desert Medical Advances Rancho Mirage, California, United States
  • Millennium Clinical Trials Simi Valley, California, United States
View all 84 locations
View Trial Details
Completed

Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)

NCT04908865

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • GSK Investigational Site Beijing, China
  • GSK Investigational Site Changchun, China
  • GSK Investigational Site Changsha, China
  • GSK Investigational Site Chongqing, China
View Trial Details
Completed

JBT-101 in Systemic Lupus Erythematosus (SLE)

NCT03093402

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +6 more
Locations
  • University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology La Jolla, California, United States
  • UCLA Medical Center: Division of Rheumatology Los Angeles, California, United States
  • University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
View all 16 locations
View Trial Details

Related conditions